Novolin Ge 30/70 30 Unit (Insulin Injection Human Biosynthetic SUSPENSION) 30 UNIT

NOVOLIN GE 30/70 30 Unit is a human biosynthetic insulin suspension designed for subcutaneous administration. It combines rapid-acting and intermediate-acting insulin to manage blood glucose levels. Ideal for diabetes management, this 10mL suspension offers a balanced approach to insulin therapy.

Strength

30 UNIT

Pack Size

10ML

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NOVOLIN GE 30/70 30 Unit is primarily used for the management of diabetes mellitus. This insulin suspension helps regulate blood sugar levels by providing both immediate and prolonged insulin effects. It is often prescribed for individuals who require a combination of rapid-acting and intermediate-acting insulin to maintain stable glucose control throughout the day.

Side Effects

When administered subcutaneously, NOVOLIN GE 30/70 30 Unit works to lower blood sugar levels. Users may experience effects such as reduced hunger and improved energy levels as blood glucose is managed. It is important to monitor blood sugar levels regularly to assess the effectiveness of the treatment.

Precautions & Warnings

NOVOLIN GE 30/70 30 Unit should be stored properly to maintain its efficacy. It is crucial to follow the storage instructions provided to ensure the insulin remains effective. Always check the suspension for any changes in appearance before use. Consult a healthcare provider for personalized advice on handling and storage.

Avoid Interactions

NOVOLIN GE 30/70 30 Unit may interact with other medications, including oral hypoglycemic agents and certain antibiotics. Alcohol consumption can also affect blood sugar levels and should be monitored closely. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

NOVOLIN GE 30/70 30 Unit is used for the management of diabetes mellitus, providing both rapid-acting and intermediate-acting insulin effects.

NOVOLIN GE 30/70 30 Unit is designed for subcutaneous administration, typically injected under the skin.

Common effects include reduced hunger and improved energy levels as blood sugar levels are regulated.

Proper storage and handling are crucial. Always check the suspension for any changes in appearance before use.

Yes, it may interact with oral hypoglycemic agents and certain antibiotics. Always inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.